These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38164199)

  • 1. The effect on blink frequency of a selective blue-filtering photochromic lens in patients with benign essential blepharospasm.
    Monschein T; Zrzavy T; Weber C; Kuzmina Z; Gutstein W; Sycha T
    Front Neurol; 2023; 14():1301947. PubMed ID: 38164199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm.
    Blackburn MK; Lamb RD; Digre KB; Smith AG; Warner JE; McClane RW; Nandedkar SD; Langeberg WJ; Holubkov R; Katz BJ
    Ophthalmology; 2009 May; 116(5):997-1001. PubMed ID: 19410958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm.
    Schwingenschuh P; Katschnig P; Edwards MJ; Teo JT; Korlipara LV; Rothwell JC; Bhatia KP
    Neurology; 2011 Feb; 76(7):610-4. PubMed ID: 21321334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.
    Lai KKH; Tsang A; Kuk AKT; Ko CKL; Chan E; Ko STC
    Neuroophthalmology; 2021; 45(5):293-300. PubMed ID: 34566211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm.
    Quartarone A; Sant'Angelo A; Battaglia F; Bagnato S; Rizzo V; Morgante F; Rothwell JC; Siebner HR; Girlanda P
    J Neurosci; 2006 Jan; 26(2):716-21. PubMed ID: 16407569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of blink adaptation in the pathophysiology of benign essential blepharospasm.
    Hasan SA; Baker RS; Sun WS; Rouholiman BR; Chuke JC; Cowen DE; Porter JD
    Arch Ophthalmol; 1997 May; 115(5):631-6. PubMed ID: 9152131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial magnetic brain stimulation modulates blepharospasm: a randomized controlled study.
    Kranz G; Shamim EA; Lin PT; Kranz GS; Hallett M
    Neurology; 2010 Oct; 75(16):1465-71. PubMed ID: 20956792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for investigating benign essential blepharospasm.
    Evinger C
    Curr Neuropharmacol; 2013 Jan; 11(1):53-8. PubMed ID: 23814538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
    Alexandru H; Muthuraman M; Chirumamilla VC; Koirala N; Paktas B; Deuschl G; Zeuner KE; Groppa S
    PLoS One; 2016; 11(12):e0168652. PubMed ID: 27992533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bangerter occlusion foils on blepharospasm and hemifacial spasm in occlusion-positive and occlusion-negative patients.
    Malhotra R; Then SY; Richards A; Cheek E
    Open Ophthalmol J; 2010 Jan; 4():1-6. PubMed ID: 20148097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign essential blepharospasm among residents of Olmsted County, Minnesota, 1976 to 1995: an epidemiologic study.
    Bradley EA; Hodge DO; Bartley GB
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):177-81. PubMed ID: 12918550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Dynamic Circuit Hypothesis for the Pathogenesis of Blepharospasm.
    Peterson DA; Sejnowski TJ
    Front Comput Neurosci; 2017; 11():11. PubMed ID: 28326032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A resting state functional magnetic resonance imaging study of patients with benign essential blepharospasm.
    Zhou B; Wang J; Huang Y; Yang Y; Gong Q; Zhou D
    J Neuroophthalmol; 2013 Sep; 33(3):235-40. PubMed ID: 23636105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of patients with blepharospasm: a report of 240 patients.
    Peckham EL; Lopez G; Shamim EA; Richardson SP; Sanku S; Malkani R; Stacy M; Mahant P; Crawley A; Singleton A; Hallett M
    Eur J Neurol; 2011 Mar; 18(3):382-6. PubMed ID: 20649903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
    Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensory Trick Frames: A New Device for Blepharospasm Patients.
    Lorenzano D; Tansley S; Ezra DG
    J Mov Disord; 2019 Jan; 12(1):22-26. PubMed ID: 30642155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.